Archit Organosys Ltd vs Epigral Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 19, 2026

Key Highlights

The Latest Trading Price of Archit Organosys Ltd is ₹ 37.1 as of 19 Mar 10:07 . The P/E Ratio of Archit Organosys Ltd changed from 10.9 on March 2023 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Epigral Ltd changed from 11.1 on March 2023 to 22.9 on March 2025 . This represents a CAGR of 15.59% over 5 years The Market Cap of Archit Organosys Ltd changed from ₹ 123.92 crore on March 2023 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Epigral Ltd changed from ₹ 3919 crore on March 2023 to ₹ 8191 crore on March 2025 . This represents a CAGR of 15.89% over 5 years The revenue of Archit Organosys Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Epigral Ltd for the Dec '25 is ₹ 602.68 crore as compare to the Sep '25 revenue of ₹ 589.1 crore. This represent the growth of 2.31% The ebitda of Archit Organosys Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Epigral Ltd for the Dec '25 is ₹ 108.26 crore as compare to the Sep '25 ebitda of ₹ 133.8 crore. This represent the decline of -19.09% The net profit of Archit Organosys Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Epigral Ltd changed from ₹ 85.87 crore to ₹ 39.11 crore over 7 quarters. This represents a CAGR of -36.20% The Dividend Payout of Archit Organosys Ltd changed from 14.99 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Epigral Ltd changed from 5.88 % on March 2023 to 7.26 % on March 2025 . This represents a CAGR of 7.28% over 3 years .

About Archit Organosys Ltd

Archit Organosys Limited was originally incorporated on 04th August 1993 as 'Shri Chlochem Limited'.
The Company got the name changed to Archit Organosys Limited from Shri Chlochem Limited effective from 19th May, 2012.
The Company is mainly engaged in the business of manufacturing and trading of various chemical products. Major customers of the Company include several large Indian and International companies who are engaged in the Agrochemical Manufacturing Sector, Pharmaceuticals Manufacturing Sector and Cosmetics Manufacturing Sector.
Company has developed various product like MCA, SMCA, CAC and TCAC. Company is selling their products across Pan India as well as USA, Europe, Latin America, Other Asian Countries and South Africa.
These products are used mainly in pharmaceutical Intermediates like Ibuprofen, Diclofenac, Aceclofenac, Oil field chemicals used for Oil Drilling mainly In CMC manufacturing, Agriculture field product majorly 2,4 D-Acid and many others, surfactants and cosmetic products as well as day to day personal use products, also used in Pigment.

About Epigral Ltd

Epigral Limited was erstwhile incorporated as 'Meghmani Finechem Limited' in 2007, which is engaged in manufacturing and selling of Chlor Alkali & its Derivatives and also in Trading of Agrochemical products.
The Company was incorporated as a subsidiary of Meghmani Organics Limited. Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern, through the Scheme of Arrangement for Demerger and the said Scheme became effective from May 10, 2021.
The Chlor-Alkali business commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 2020-21.
The Company is now among the leading players in India's chlor alkali industry.
In terms of the said Scheme, the Company allotted 2,39,03,029 Equity Shares of Rs 10/- each on 20th May, 2021 to the shareholders of Meghmani Organics Limited.

FAQs for the comparison of Archit Organosys Ltd and Epigral Ltd

Which company has a larger market capitalization, Archit Organosys Ltd or Epigral Ltd?

Market cap of Archit Organosys Ltd is 77 Cr while Market cap of Epigral Ltd is 3,694 Cr

What are the key factors driving the stock performance of Archit Organosys Ltd and Epigral Ltd?

The stock performance of Archit Organosys Ltd and Epigral Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Archit Organosys Ltd and Epigral Ltd?

As of March 19, 2026, the Archit Organosys Ltd stock price is INR ₹38.0. On the other hand, Epigral Ltd stock price is INR ₹856.45.

How do dividend payouts of Archit Organosys Ltd and Epigral Ltd compare?

To compare the dividend payouts of Archit Organosys Ltd and Epigral Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.